- 3 November 2016 Creation of YposKesi
- 18 December 2015 Genethon and CRISPR Therapeutics announce Research Collaboration
- 5 October 2015 The treatment of rare diseases requires extreme refinement (La Recherche)
Created in 1990 by AFM-TELETHON, Genethon is fully dedicated to the design and development of gene therapy treatments for rare diseases. Its objective is to provide these innovative treatments to patients affected with rare disorders.
Genethon is developing therapies for rare neuromuscular diseases, immune system or blood disorders, eye disorders and liver diseases.